Literature DB >> 12928960

Gadobutrol-enhanced moving-table magnetic resonance angiography in patients with peripheral vascular disease: a prospective, multi-centre blinded comparison with digital subtraction angiography.

Annette Hentsch1, Manuela A Aschauer, Jörn O Balzer, Joachim Brossmann, Hans P Busch, Kirsten Davis, Philippe Douek, Franz Ebner, Jos M A van Engelshoven, Michaela Gregor, Christian Kersting, Patrick R Knüsel, Edward Leen, Tim Leiner, Christian Loewe, Simon McPherson, Peter Reimer, Fritz K W Schäfer, Matthias Taupitz, Siegfried A Thurnher, Bernd Tombach, Robin Wegener, Dominik Weishaupt, James F M Meaney.   

Abstract

The purpose of this study was to compare moving-table three-dimensional contrast-enhanced magnetic resonance angiography (CE MRA), using 1.0-mol gadobutrol, with intra-arterial digital subtraction angiography (i.a. DSA) for evaluation of pelvic and peripheral arteries in patients with peripheral arterial occlusive disease. A total of 203 patients were examined in a prospective, multi-centre study at 1.0/1.5 T. Ten vessel segments of one leg were evaluated on-site and by three independent blinded reviewers off-site. One hundred eighty-two patients were evaluable in blinded reading. For pelvis and thigh, there was statistically significant diagnostic agreement between CE MRA and i.a. DSA on-site (94%) and off-site (86-88%). Overall, for detection of clinically significant stenoses, 93% sensitivity and 90% specificity were achieved in on-site evaluation, with 71-76 and 87-93% off-site; for detection of occlusion, sensitivity and specificity on-site were 91 and 97%, with 75-82 and 94-98% off-site. Evaluation was more sensitive on-site than off-site for detection of stenoses and occlusion, whereas specificity was similar. The CE MRA with 1.0-mol gadobutrol gave results comparable to those of i.a. DSA for the larger arteries of pelvis and thigh. Results for calf arteries were compromised by spatial resolution and technical limitations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12928960     DOI: 10.1007/s00330-003-1844-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  31 in total

1.  3D contrast-enhanced MR angiography of the run-off vessels: value of image subtraction.

Authors:  S G Ruehm; D Nanz; A Baumann; M Schmid; J F Debatin
Journal:  J Magn Reson Imaging       Date:  2001-03       Impact factor: 4.813

2.  Need for background suppression in contrast-enhanced peripheral magnetic resonance angiography.

Authors:  T Leiner; T T de Weert; R J Nijenhuis; G B Vasbinder; A G Kessels; K Y Ho; J M van Engelshoven
Journal:  J Magn Reson Imaging       Date:  2001-12       Impact factor: 4.813

3.  Aortoiliac and lower extremity arteries: comparison of three-dimensional dynamic contrast-enhanced subtraction MR angiography and conventional angiography.

Authors:  E Sueyoshi; I Sakamoto; Y Matsuoka; Y Ogawa; H Hayashi; R Hashmi; K Hayashi
Journal:  Radiology       Date:  1999-03       Impact factor: 11.105

4.  Cardiac-gated MR angiography of the entire lower extremity: a prospective comparison with conventional angiography.

Authors:  D J Glickerman; R G Obregon; U P Schmiedl; S D Harrison; S E Macaulay; H E Simon; T R Kohler
Journal:  AJR Am J Roentgenol       Date:  1996-08       Impact factor: 3.959

5.  Peripheral vascular tree stenoses: detection with subtracted and nonsubtracted MR angiography.

Authors:  K Y Ho; M W de Haan; A G Kessels; P J Kitslaar; J M van Engelshoven
Journal:  Radiology       Date:  1998-03       Impact factor: 11.105

6.  MR angiography of the iliac and upper femoral arteries using four different inflow techniques.

Authors:  K Y Ho; M W de Haan; T K Oei; D Koster; A G Kessels; B K Janevski; P Kitslaar; J M van Engelshoven
Journal:  AJR Am J Roentgenol       Date:  1997-07       Impact factor: 3.959

7.  Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches.

Authors:  M R Prince; D L Narasimham; J C Stanley; T L Chenevert; D M Williams; M V Marx; K J Cho
Journal:  Radiology       Date:  1995-12       Impact factor: 11.105

8.  Peripheral vascular occlusive disease: accuracy and reliability of time-of-flight MR angiography.

Authors:  T R McCauley; A Monib; K W Dickey; J Clemett; G H Meier; T K Egglin; R J Gusberg; M Rosenblatt; J S Pollak
Journal:  Radiology       Date:  1994-08       Impact factor: 11.105

9.  Interpretations and treatment decisions based on MR angiography versus conventional arteriography in symptomatic lower extremity ischemia.

Authors:  J J Snidow; V J Harris; S O Trerotola; D F Cikrit; S G Lalka; K A Buckwalter; M S Johnson
Journal:  J Vasc Interv Radiol       Date:  1995 Jul-Aug       Impact factor: 3.464

10.  Multicenter trial to evaluate vascular magnetic resonance angiography of the lower extremity. American College of Radiology Rapid Technology Assessment Group.

Authors:  R A Baum; C M Rutter; J H Sunshine; J S Blebea; J Blebea; J P Carpenter; K W Dickey; S F Quinn; A S Gomes; T M Grist
Journal:  JAMA       Date:  1995-09-20       Impact factor: 56.272

View more
  16 in total

1.  Contrast media in magnetic resonance angiography.

Authors:  Georg M Bongartz
Journal:  Eur Radiol       Date:  2003-09       Impact factor: 5.315

2.  Nonenhanced magnetic resonance angiography (MRA) of the calf arteries at 3 Tesla: intraindividual comparison of 3D flow-dependent subtractive MRA and 2D flow-independent non-subtractive MRA.

Authors:  Gesine Knobloch; Marie-Teres Lauff; Sebastian Hirsch; Carsten Schwenke; Bernd Hamm; Moritz Wagner
Journal:  Eur Radiol       Date:  2016-02-10       Impact factor: 5.315

3.  Comprehensive MR angiography of the lower limbs: a hybrid dual-bolus approach including the pedal arteries.

Authors:  R Schmitt; G Coblenz; O Cherevatyy; H Brunner; S Fröhner; E Wedell; G Karg; G Christopoulos
Journal:  Eur Radiol       Date:  2005-07-22       Impact factor: 5.315

4.  Effects of injection rate and dose on image quality in time-resolved magnetic resonance angiography (MRA) by using 1.0M contrast agents.

Authors:  Harald Kramer; Henrik J Michaely; Martin Requardt; Martin Rohrer; Scott Reeder; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Eur Radiol       Date:  2006-11-18       Impact factor: 5.315

Review 5.  Gadobutrol: a review of its use for contrast-enhanced magnetic resonance imaging in adults and children.

Authors:  Lesley J Scott
Journal:  Clin Drug Investig       Date:  2013-04       Impact factor: 2.859

6.  Subtractionless first-pass single contrast medium dose peripheral MR angiography using two-point Dixon fat suppression.

Authors:  Tim Leiner; Jesse Habets; Bastiaan Versluis; Liesbeth Geerts; Eveline Alberts; Niels Blanken; Jeroen Hendrikse; Evert-Jan Vonken; Holger Eggers
Journal:  Eur Radiol       Date:  2013-04-17       Impact factor: 5.315

7.  Intra-individual, randomised comparison of the MRI contrast agents gadobutrol and gadoterate in imaging the distal lower limb of patients with known or suspected osteomyelitis, evaluated in an off-site blinded read.

Authors:  Werner Pennekamp; Daniela Roggenland; Steffen Hering; Stefan Lemburg; Soeren Peters; Sabrina Sterl; Carsten Schwenke; Volkmar Nicolas
Journal:  Eur Radiol       Date:  2010-12-21       Impact factor: 5.315

8.  Peripheral arterial disease screening and diagnostic practice: A scoping review.

Authors:  Cornelius M Donohue; Joseph V Adler; Laura L Bolton
Journal:  Int Wound J       Date:  2019-11-03       Impact factor: 3.315

9.  High-resolution 3D non-contrast-enhanced, ECG-gated, multi-step MR angiography of the lower extremities: comparison with contrast-enhanced MR angiography.

Authors:  Oliver K Mohrs; Steffen E Petersen; Martin C Heidt; Thomas Schulze; Peter Schmitt; Sabine Bergemann; Hans-Ulrich Kauczor
Journal:  Eur Radiol       Date:  2010-08-13       Impact factor: 5.315

Review 10.  [Contrast agents in MRT. Substance, effects, pharmacology and validity].

Authors:  P Reimer; R Vosshenrich
Journal:  Radiologe       Date:  2004-03       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.